跳至主要内容
临床试验/JPRN-UMIN000028962
JPRN-UMIN000028962招募中未知

Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis. - Study of symptom improvement effect of gastric secretion inhibitors in patients with reflux esophagitis.

Ikoma Gastorenteroproctorogy Clinic0 个研究点目标入组 40 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss. 2.The patients with confirmed or suspected malignant diseases. 3.The patients with a history of gastrointestinal resection of vagotomy. 4.The patients with a history of irritable bowel syndrome. 5.The patients whose participation in this study would be contraindicated due to complications such as serious heaptic, renal or heart disease. 6.The Pregnant patients or possibly pregnant patients. 7.The patients prohibited the participant of this study by their attending physicians. 8.The patients who took esomeprazole or vonoprazan within 4 weeks.

研究者

发起方
Ikoma Gastorenteroproctorogy Clinic

相似试验